Response to "Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of immune checkpoint inhibitors: A disproportionality analysis using the FDA Adverse Event Reporting System database"

• PMID: 40588131
• DOI: 10.1016/j.jaad.2025.06.060